03:46 PM EST - Bioasis Technologies Inc. : a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier, has shown that a newly discovered peptide vector form of Transcend - Transcendpep - effectively delivers siRNA across the blood-brain barrier and into brain cells. Bioasis Technologies Inc.
shares V.BTI are trading up $0.04 at $0.97.
